1. Home
  2. CRIS vs USIO Comparison

CRIS vs USIO Comparison

Compare CRIS & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • USIO
  • Stock Information
  • Founded
  • CRIS 2000
  • USIO 1998
  • Country
  • CRIS United States
  • USIO United States
  • Employees
  • CRIS N/A
  • USIO N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • USIO Investment Bankers/Brokers/Service
  • Sector
  • CRIS Health Care
  • USIO Finance
  • Exchange
  • CRIS Nasdaq
  • USIO Nasdaq
  • Market Cap
  • CRIS 32.8M
  • USIO N/A
  • IPO Year
  • CRIS 2000
  • USIO N/A
  • Fundamental
  • Price
  • CRIS $1.48
  • USIO $1.47
  • Analyst Decision
  • CRIS Strong Buy
  • USIO Strong Buy
  • Analyst Count
  • CRIS 3
  • USIO 2
  • Target Price
  • CRIS $21.00
  • USIO $5.00
  • AVG Volume (30 Days)
  • CRIS 51.0K
  • USIO 112.1K
  • Earning Date
  • CRIS 03-31-2025
  • USIO 03-26-2025
  • Dividend Yield
  • CRIS N/A
  • USIO N/A
  • EPS Growth
  • CRIS N/A
  • USIO N/A
  • EPS
  • CRIS N/A
  • USIO 0.12
  • Revenue
  • CRIS $10,908,000.00
  • USIO $82,931,840.00
  • Revenue This Year
  • CRIS N/A
  • USIO $15.85
  • Revenue Next Year
  • CRIS $27.88
  • USIO $12.86
  • P/E Ratio
  • CRIS N/A
  • USIO $12.17
  • Revenue Growth
  • CRIS 8.83
  • USIO N/A
  • 52 Week Low
  • CRIS $1.42
  • USIO $1.24
  • 52 Week High
  • CRIS $17.49
  • USIO $2.92
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 18.52
  • USIO 43.08
  • Support Level
  • CRIS $2.57
  • USIO $1.48
  • Resistance Level
  • CRIS $2.62
  • USIO $1.73
  • Average True Range (ATR)
  • CRIS 0.26
  • USIO 0.09
  • MACD
  • CRIS -0.07
  • USIO 0.01
  • Stochastic Oscillator
  • CRIS 10.88
  • USIO 27.78

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: